Walmart to pay $50 million to settle DOJ opioid prescription allegations
The Justice Department and the Drug Enforcement Administration announced a $50 million settlement with Walmart Inc. to resolve allegations that the company's pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances, in violation of the Controlled Substances Act.
The Justice Department and the Drug Enforcement Administration have reached a $50 million settlement with Walmart. This agreement resolves allegations that Walmart pharmacies filled numerous invalid prescriptions for opioids and other controlled substances. These actions were in violation of the Controlled Substances Act.
- Walmart has agreed to a $50 million settlement with the Justice Department and the Drug Enforcement Administration.
- The settlement resolves allegations that Walmart’s pharmacies illegally filled thousands of invalid prescriptions.
- The prescriptions in question were for opioids and other controlled substances.
- The company’s actions are alleged to be in violation of the Controlled Substances Act.
Write a comment